-
Mashup Score: 0
A subgroup of patients from the 3 CARTITUDE trials experienced cranial nerve palsy after treatment, most of whom were men.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
As symptom severity can vary by patient, it is key for nurses to increase assessment for early intervention of patients with head and neck cancer following treatment, according to Meredith Cummings, PhD(c), BSN, RN, OCN.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Establishing a nurse-led system to administer tocilizumab in patients receiving bispecific antibodies tended to get the immunosuppressive drug to patients faster.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Patient-Reported Symptoms via Mobile App May Help Expedite GVHD Identification, Treatment - 1 day(s) ago
A feasibility study on the use of a mobile application for patients after undergoing a stem cell transplant may help care teams quickly identify and treat graft-versus-host disease.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Patients who were given telehealth, vs in-person, exercise programs to manage their symptoms from cancer care experienced similar outcomes, highlighting an alternative for providers to consider.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Results from the CARTITUDE-2 trial support cilta-cel in patients with multiple myeloma, which addresses the unmet needs of these patients, an expert presented.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6
An oncology nurse details strategies used at his institution to reduce burnout — which can ultimately decrease the rate of “silent quitting.”
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Relapsed/Refractory Follicular Lymphoma May Respond to Loncastuximab Tesirine Plus Rituximab - 1 day(s) ago
Encouraging responses were observed in most patients with relapsed/refractory follicular lymphoma treated with loncastuximab tesirine and rituximab.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Patients in the CARTITUDE-4 trial experienced a high response rate to the treatment as early as their first relapse.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The establishment of a multidisciplinary committee can help identify opportunities to best face the ongoing cancer drug shortage.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
A subgroup of patients from the 3 CARTITUDE trials experienced cranial nerve palsy after treatment, most of whom were men. https://t.co/zV8CQHkdbI https://t.co/A3hAkxIBqB